KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

BioNTech SE (BNTX) Revenue: 2017-2024

Historic Revenue for BioNTech SE (BNTX) over the last 8 years, with Dec 2024 value amounting to $2.9 billion.

  • BioNTech SE's Revenue rose 29.89% to $1.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 billion, marking a year-over-year increase of 7.09%. This contributed to the annual value of $2.9 billion for FY2024, which is 28.45% down from last year.
  • Per BioNTech SE's latest filing, its Revenue stood at $2.9 billion for FY2024, which was down 28.45% from $4.1 billion recorded in FY2023.
  • In the past 5 years, BioNTech SE's Revenue registered a high of $21.7 billion during FY2021, and its lowest value of $575.0 million during FY2020.
  • In the last 3 years, BioNTech SE's Revenue had a median value of $4.1 billion in 2023 and averaged $8.2 billion.
  • As far as peak fluctuations go, BioNTech SE's Revenue soared by 3,675.17% in 2021, and later crashed by 76.73% in 2023.
  • BioNTech SE's Revenue (Yearly) stood at $575.0 million in 2020, then soared by 3,675.17% to $21.7 billion in 2021, then dropped by 18.65% to $17.7 billion in 2022, then slumped by 76.73% to $4.1 billion in 2023, then declined by 28.45% to $2.9 billion in 2024.